T-Cypher Bio
Eleanor Bagg is an experienced Senior Scientist who has worked at companies such as T-Cypher Bio and Adaptimmune, specializing in Protein Sciences, Cell Biology, and Target Discovery. Eleanor has a diverse skill set including protein expression and purification, molecular biology techniques, cell culture, ELISA, flow cytometry, project management, and target assessment. Eleanor also has a background in Clinical Biochemistry, having completed the Scientist Training Programme and worked at Imperial College Healthcare NHS Trust. Eleanor holds a DPhil in Biochemistry from the University of Oxford, where Eleanor also completed their undergraduate degree in Chemistry. Throughout their career, Eleanor has demonstrated a strong research background and expertise in various scientific disciplines.
This person is not in any teams
T-Cypher Bio
T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of suchtherapies.T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.